Skip to content

Liraglutide

Liraglutide, known in this catalogue as Victoza, is used for type 2 diabetes. This listing contains one 6mg auto-injector formulation of liraglutide.

Victoza

Type 2 Diabetes Mellitus

6mg

Liraglutide auto-injector for type 2 diabetes. It helps the body release insulin when blood sugar rises.

From$401.50/ auto-injectorView

Key points

  • The boxed warning describes thyroid C-cell tumours in rats and mice at clinically relevant exposures.
  • The human risk of thyroid C-cell tumours, including medullary thyroid carcinoma, remains unknown.
  • Liraglutide is not suitable with a personal or family history of medullary thyroid carcinoma or with multiple endocrine neoplasia syndrome type 2.

Common questions about liraglutide

What is liraglutide?

Liraglutide is an analogue of human GLP-1 and a GLP-1 receptor agonist. It acts like a natural hormone involved in blood sugar regulation. In this catalogue, it is listed as Victoza for Type 2 Diabetes Mellitus.

Which thyroid symptoms are noted for liraglutide?

The Victoza label notes a mass in the neck, difficulty swallowing, difficulty breathing and persistent hoarseness as symptoms of thyroid tumours. Routine calcitonin testing or thyroid ultrasound has uncertain value for finding medullary thyroid carcinoma early.

Further reading